Weekly Reports | Jul 08 2011
Our top ten news from 30 June 2011 to 07 July 2011 (ranked according to popularity).
In the wake of Fukushima, Goldman Sachs has increased its long term uranium forecast price which seems at odds with the implications and subsequent spot price movements.
This story was first published two days ago in the form of an email sent to registered FNArena readers. By Rudi Filapek-Vandyck, Editor FNArena The case for a widely anticipated rally in risk assets, carried by improving economic data in the second half of the year, re
Microcap listing Hastings Rare Metals boasts one of only four JORC-compliant rare earth metals resources in Australia and has Lynas is its sights. What really is the rare earth story?
Risk assets have done it tough since late April. Technical analysis by ATW suggests this process is coming to and end. ATW seems to favour break-outs to the upside.
While recent share price weakness has improved the value on offer, Morgan Stanley suggests it remains too early to be a buyer of CSL.
Maybe a recovery in the domestic economy is not going to translate into an ever tighter labour market in Australia?
Investment U's Tony D'Altorio explains why investors should keep an eye on Spain and Italy, instead of Greece, Ireland or Portugal.
The stockbroker formerly known as Southern Cross Equities (now Bell Potter) has reiterated its Speculative Buy rating on Starpharma.
Barclays Capital's analysis of seasonal trends for July shows mixed results across equity markets, but commodities, copper in particular, should perform strongly.
Top Ten Weekly Recommendation, Target Price, Earning Forecast Changes
Monday 04 July 2011 – 10:06 AM
Weekly update on recommendation, target price, and earning forecast changes.